Pharmacokinetics and Pharmacodynamics of Naloxone
- PMID: 31002450
- DOI: 10.1111/acem.13768
Pharmacokinetics and Pharmacodynamics of Naloxone
Comment on
-
Hospital Observation Upon Reversal (HOUR) With Naloxone: A Prospective Clinical Prediction Rule Validation Study.Acad Emerg Med. 2019 Jan;26(1):7-15. doi: 10.1111/acem.13567. Epub 2018 Dec 28. Acad Emerg Med. 2019. PMID: 30592101
-
HOUR Prediction Rule.Acad Emerg Med. 2019 Oct;26(10):1201-1202. doi: 10.1111/acem.13769. Epub 2019 May 23. Acad Emerg Med. 2019. PMID: 31002439 No abstract available.
References
-
- Rzasa Lynn R, Galinkin J. Naloxone dosage for opioid reversal: current evidence and clinical implications. Ther Adv Drug Saf 2018;9:63-88.
-
- Eggleston W, Podolak C, Sullivan RW, Pacelli L, Keenan M, Wojcik S. A randomized usability assessment of simulated naloxone administration by community members. Addiction 2018;113:2300-4.
-
- Neale J, Strang J. Naloxone-does over-antagonism matter? Evidence of iatrogenic harm after emergency treatment of heroin/opioid overdose. Addiction 2015;110:1644-52.
-
- Barton ED, Ramos J, Colwell C, Benson J, Baily J, Dunn W. Intranasal administration of naloxone by paramedics. Prehosp Emerg Care 2002;6:54-8.
-
- Klebacher R, Harris MI, Ariyaprakai N, et al. Incidence of naloxone redosing in the age of the new opioid epidemic. Prehosp Emerg Care 2017;21:682-7.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources